Home/Filings/4/0001209191-21-002828
4//SEC Filing

Maloberti Renaud Bertrand 4

Accession 0001209191-21-002828

CIK 0001681682other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 7:11 PM ET

Size

4.9 KB

Accession

0001209191-21-002828

Insider Transaction Report

Form 4
Period: 2021-01-08
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2021-01-08$0.94/sh8,731$8,20721,580 total
Footnotes (1)
  • [F1]Represents shares sold pursuant to a Rule 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001744025

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 7:11 PM ET
Size
4.9 KB